Pimozide,

Code: p1793-500mg D2-231

Biochem/physiol Actions

D2 dopamine receptor antagonist; binds with high affinity to the cloned 5-HT7 receptor; Ca2+ channel antagonist; anti...


read more

Your Price
£111.00 500MG
£133.20 inc. VAT
REQUEST

Biochem/physiol Actions

D2 dopamine receptor antagonist; binds with high affinity to the cloned 5-HT7 receptor; Ca2+ channel antagonist; antipsychotic

Features and Benefits

This compound was developed by Teva. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is featured on the Cyclic Nucleotide-Gated (CNG) and Hyperpolarization Activated Cyclic Nucleotide-Gated (HCN) Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

Packaging

1 g in glass bottle

500 mg in glass bottle

formpowder
Gene Informationhuman ... ABCB1(5243), CACNA1G(8913), CYP3A4(1576), DRD1(1812), DRD2(1813), DRD3(1814), DRD4(1815), DRD5(1816), HTR2A(3356), HTR7(3363), KCNH1(3756), KCNH2(3757), OPRD1(4985)mouse ... Abcb1a(18671), Abcb1b(18669)rat ... Scnn1g(24768)
InChI keyYVUQSNJEYSNKRX-UHFFFAOYSA-N
InChI1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)
originatorTeva
Quality Level200
SMILES stringFc1ccc(cc1)C(CCCN2CCC(CC2)N3C(=O)Nc4ccccc34)c5ccc(F)cc5
solubilityH2O: insoluble(lit.), chloroform: 5 mg/mL, DMSO: 18 mg/mL(lit.)
storage temp.2-8°C
Code
Description
Unit Size
List Price
Qty
P1793-1G
Pimozide,

Unit:1G
List Price: £162.00
Source:List Price
ADD
Cas Number2062-78-4
This product has met the following criteria to qualify for the following awards: